Overcoming the barriers to treatment of multi-drug resistant Gram-negative bloodstream infections in Australian children

迫切需要为患有抗生素耐药性感染的儿童开发新的治疗方法。引起耐药感染的最重要的细菌被称为革兰氏阴性菌。治疗耐药革兰氏阴性菌感染儿童的医生面临着很少的抗生素选择。该项目将发现澳大利亚儿童中最重要的耐药感染，并试验一种新的抗生素，以帮助医生以正确的剂量将其用于正确的儿童。

There is a critical need to develop new treatments for children with antibiotic resistant infections. The most important bacteria causing resistant infections are known as Gram-negative bacteria. Doctors treating children with resistant Gram-negative infections are faced with few antibiotic options. This project will discover the most important resistant infections in Australian children, and trial a new antibiotic to help doctors to use it in the right children and at the right dose.